Macrogenics (MGNX) Tops Q2 EPS, Revenues Miss

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of $0.92, $1.44 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $29.19 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Douglas Elliman (DOUG) Reports Q2 Loss of $0.05
• National Healthcare (NHC) Tops Q2 EPS by 174c